Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4

NCT00277862 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Pegylated IFN- alpha 2b
DRUG: Ribavirin

Sponsor

Ain Shams University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]